IFNA1 and hepatocellular carcinoma: In addition, we found that dihydropyridine dehydrogenase (DPYD), a pyrimidine catabolic enzyme, was downregulated in HCC tissues depending on the dose of IFN-α, and might be a potential prognostic biomarker and a therapeutic target for HCC [10].